Injective Protocol's native token INJ fell sharply over the past session, dropping 7.89% to trade at $5.20. Technical indicators now suggest the asset is in oversold territory, setting up a potential bounce. Traders are watching the $6.30 resistance level as a possible target over the next seven days.
The sharp 7.89% decline
The move lower brought INJ to $5.20, a level not seen in recent sessions. The drop comes amid broader market pressure, though specific catalysts remain unclear. The decline was steep enough to trigger oversold readings on key momentum indicators, a condition that often precedes a short-term recovery in price.
Oversold signals from technical indicators
Indicators such as the Relative Strength Index have dipped into oversold territory, suggesting the selling may have been overdone. In the past, similar readings on INJ have led to a price snapback within days. The current setup mirrors those prior patterns, though past performance does not guarantee future results. An oversold reading means the price has fallen too far too fast relative to its recent average, often leading to a corrective bounce.
Price target and resistance at $6.30
Analysts watching the charts identify $6.30 as the nearest resistance level. A move to that price would represent a gain of more than 21% from the current $5.20. The seven-day window for this potential bounce is based on typical mean reversion timeframes seen after oversold extremes.
Investors will be watching if volume picks up to confirm any upward move. A failure to hold above $5.00 could invalidate the bounce thesis. The next few sessions will be critical for INJ's short-term direction.
